
Singapore Top Medical AI 2026: 10 Platforms and Local Rules
Summary & Key Takeaway
Singapore is one of the few countries where the rules for healthcare AI are specific enough to use in a buying decision. The Ministry of Health and the Health Sciences Authority refreshed the AI in Healthcare Guidelines in 2026, the PDPA governs cross-border data transfers, and the Health Information Act adds national record-sharing duties. This guide compares 10 platforms against those rules, not against a generic global leaderboard.
◆ Core Insights
- AIHGle 2.0, launched in March 2026, sets responsibilities for developers, healthcare organisations, and clinicians, and makes human oversight and accountability explicit.
- HSA regulates AI as a medical device by intended use. A tool that recommends a diagnosis or treatment can be a device even if it looks like a chatbot.
- The PDPA allows overseas processing only with comparable protection. Check where the model runs, not just where the vendor is headquartered.
- The Health Information Act and the revised SMC Ethical Code add record-sharing, cybersecurity, and consent duties from 2027.
- For patients in Singapore, Premedice is strongest for cited lab explanations, Ada and Ubie are strong structured symptom tools, and HealthHub is the local health-system front door.
Try it yourself — free
Experience the medical AI that powers this article. Ask questions, check symptoms, or analyze lab results.
Want to see what a tool does with a panel like yours? See how the lab interpreter reads a blood panel. Compare plans.
Related Lab Tests
What Singapore gets right
Singapore's advantage is not that it has more AI tools. It is that the rules are written down. The AI in Healthcare Guidelines, known as AIHGle, were first issued in 2021 and refreshed as AIHGle 2.0 in March 2026. They address developers, healthcare organisations, and clinicians separately, which is useful because the accountability for a clinical AI tool is not the same for the company that builds it, the clinic that deploys it, and the doctor who uses it.
AIHGle 2.0 recognises seven principles: safety, fairness, transparency, explainability, robustness, security and data protection, and alignment with human values. It separates clinical uses, where AI supports diagnosis, monitoring, or treatment, from clinical-operations uses, where AI supports workflow but does not directly change clinical judgment. That distinction matters when you are deciding whether a tool needs HSA review.
The second advantage is the surrounding legal stack. The PDPA governs personal data and cross-border transfers. The Health Information Act, passed in January 2026, requires licensed providers to contribute key health information to the National Electronic Health Record and to meet cybersecurity and data-security duties on a phased timeline. The Singapore Medical Council's revised Ethical Code, in force from 1 January 2027, keeps the doctor accountable for records made on their behalf, including records drafted by an AI scribe.
The 10 platforms at a glance
The table separates patient tools, clinician tools, and local health-system infrastructure. They are not interchangeable. A patient does not need a hospital agent platform, and a hospital does not need a consumer symptom chat.
| Platform | Best for | Local fit | Main limit |
|---|---|---|---|
| Premedice | Cited lab and symptom explanations | Global product, PDPA review needed | Not a diagnosis |
| Ada | Structured symptom interview | Consumer app | Less lab depth |
| Ubie | Fast symptom triage | Consumer web | Narrower context |
| DrKhan | Anonymous lab and symptom chat | Consumer web | Limited continuity |
| Doctronic | US video-visit path | US-focused | Record retention; US clinicians |
| Docus | Human second opinion network | Global | Not a pure interpreter |
| ChatGPT Health | General health conversation | Global | Not a diagnosis |
| HealthHub | Singapore health records and services | Local health system | Not an AI diagnostician |
| Synapxe AgentSea | Public healthcare AI agents | Public healthcare | Not a consumer product |
| Rezonate (KeyReply) | Patient engagement across public hospitals | Local hospitals | Enterprise deployment |
Best for patients in Singapore
For a lab report with a question, Premedice is the strongest fit in this group. It reads the report's own reference ranges, explains patterns across markers, cites sources, and processes the report in memory without keeping a permanent record. The caveat is data residency: a global product requires a PDPA transfer assessment before you upload identifiable information. De-identifying the report is the simplest safe workflow. For the general category, see our best AI for blood test interpretation.
Ada and Ubie are the strongest free structured symptom tools. Ada asks adaptive follow-up questions and gives a care recommendation. Ubie is faster and easier to finish. Neither is a diagnosis, and neither replaces a local GP or polyclinic. DrKhan is the simplest anonymous option for a one-off lab question. For the structured category, see our best AI symptom checker.
HealthHub is the local front door for records, appointments, and health information. It is not a diagnostic AI, but it is the right place to check your Singapore health record and the services you are eligible for. For a patient, the practical stack is HealthHub for the record, a cited AI tool for the explanation, and a local clinician for the decision.
Best for clinicians in Singapore
Clinicians have a different job. They need evidence retrieval, differential support, documentation, and a clear audit trail. EvidenceMD is the most Singapore-specific clinician comparison in the market, with a detailed review of AIHGle 2.0, HSA, PDPA, and the SMC code. OpenEvidence is an excellent free evidence engine, but its availability in Singapore is not confirmed and it may require a US NPI. Do not assume access.
The public healthcare clusters have their own tools. SingHealth's Note Buddy transcribes and summarises consultations, and Synapxe's AgentSea lets public healthcare professionals create and share AI agents. These are not consumer products, and they are usually the approved route for identifiable patient data inside the public system. For the broader product layer, see our best AI medical platforms.
The practical rule for a private clinician is to use the tool your institution has assessed for identifiable data, and to use a global tool only with de-identified information unless the PDPA assessment covers the vendor. AIHGle 2.0 makes the clinician accountable for what they enter and for the accuracy of what they use.
Best for hospitals and clinics
Hospitals and clinics are deployers, not users. They need vendor assessment, integration, cybersecurity, staff training, and a registry of AI tools. AIHGle 2.0 asks organisations to keep that registry and to specify which data types may be entered into each tool.
The local vendors to know include Synapxe for public healthcare infrastructure, Rezonate for patient engagement, and implementation firms such as Tech JDI for custom integration. The choice is less about the model and more about the workflow: can the tool connect to the hospital management system, the EHR, billing, and the patient channels the organisation already uses?
The most common mistake is buying a consumer chatbot and calling it a clinical tool. A consumer chatbot has no clinical governance, no integration, no audit trail, and no clear intended use. A clinical deployment needs all four. For the patient-safety side, see our AI doctor safety guide.
The rules that matter
AIHGle 2.0 is the starting point. It sets out responsibilities across the AI lifecycle and emphasises human oversight, transparency, and risk mitigation. For a clinician, the practical obligations are to understand the tool's intended use, to recognise hallucinations, to fact-check and source-check outputs, and to keep the skills to work without AI.
HSA regulates AI as a medical device by intended use. Software that investigates, detects, diagnoses, prevents, monitors, treats, or manages a medical condition can be a medical device. A tool that only displays or prints information, or whose output is based solely on established clinical guidelines, may fall outside device regulation. The line is not a marketing choice; it is the intended use.
| Role | What it owns | Question to ask |
|---|---|---|
| Developer | Safe design, validation, transparency, post-market monitoring | What evidence supports the intended use? |
| Deployer | Vendor assessment, data classification, staff rules, registry | Where does the data go and who approved it? |
| User | Intended use, verification, red flags, record quality | Can I explain and defend this output? |
The PDPA and the Health Information Act
Ask three questions. Where is the data stored? Where is the model inference run? What happens to the data after the session? A vendor can store data in Singapore and still send it overseas for inference. A vendor can also process in Singapore and keep a copy elsewhere.
The PDPA governs personal data. Section 26 restricts transfers of personal data outside Singapore unless the recipient is bound by legally enforceable obligations or holds a specified certification. A vendor's HIPAA BAA is a US instrument; it does not automatically satisfy the PDPA. The Health Information Act adds NEHR contribution and cybersecurity duties, phased from 2027.
Data residency: what to ask
Ask three questions. Where is the data stored? Where is the model inference run? What happens to the data after the session? A vendor can store data in Singapore and still send it overseas for inference. A vendor can also process in Singapore and keep a copy elsewhere.
The answers vary by product. Some global models offer Singapore processing on specific cloud regions and specific model versions. Others offer only at-rest residency, or only a global endpoint. A PDPA assessment should name the model, the endpoint, and the retention period, not just the country of the headquarters.
The simplest safe workflow is to de-identify before you upload. Remove the patient's name, NRIC, date of birth, address, and any other identifier that is not needed for the explanation. If the tool cannot work without identifiers, the data residency question becomes a formal assessment, not a checkbox.
Cost and access
AI tools are not a substitute for subsidised care. Singapore residents should use HealthHub, their polyclinic, or their GP for care, and use AI to understand the document and prepare questions. A consumer AI subscription is not a health insurance plan.
For a private clinic, the cost of an AI tool is not the subscription alone. It includes integration, training, cybersecurity review, and the time to validate the workflow. A cheap tool that creates a new data-protection problem is not cheap.
For a patient, the free tiers are enough to test the workflow. Use a free chat or a free lab explanation first. Pay only when the tool saves you a visit or helps you avoid an unnecessary test.
How to choose
Start with the job. If you are a patient with a lab report, choose a cited interpreter with a clear retention policy. If you have a symptom, choose a structured checker that escalates red flags. If you need a second opinion, choose a human network, not a chatbot.
Then check the governance. Who reviewed the medical content? What is the intended use? Is it registered with HSA if it meets the device definition? Where does the data go? Can you delete it? Does the vendor have a Singapore entity or a PDPA-ready contract?
Finally, test the failure mode. Ask a red-flag question. Upload a report with a missing unit. Ask what the tool cannot do. A tool that fails the failure-mode test is not ready, regardless of its accuracy claims.
| User | First choice | Why |
|---|---|---|
| Patient with a lab report | Premedice | Cited ranges, patterns, low retention |
| Patient with a symptom | Ada or Ubie | Structured triage |
| Patient who wants anonymity | DrKhan | No signup |
| Clinician who needs evidence | Institution-approved tool or EvidenceMD | AIHGle and PDPA fit |
| Public hospital team | Synapxe / cluster tools | Approved data path |
| Private clinic | Local integrator plus a governed tool | Workflow and compliance |
Bottom line
Singapore does not need another generic best medical AI list. It needs tools that can answer the local questions: where does the data go, who is accountable, what is the intended use, and how does the clinician verify the output? The platforms that answer those questions will win. The ones that cannot will remain demos.
For patients, start with HealthHub for the record, Premedice for the explanation, and a local clinician for the decision. For clinics, start with the governance, then choose the product.
Ready to try Premedice?
Get instant, AI-powered explanations of your lab results and symptoms — powered by 45+ clinical sources.
Continue Reading
Most Popular
MedGemma: Open-Source Medical AI That Runs on Your Hardware
TechnologyMed-PaLM 2: 86.5% MedQA Score, Zero Doctors Using It (2026)
ResearchWhich Medical AI Can You Actually Trust With Your Bloodwork?
ResearchGoogle's MedGemma Is Free - But Should You Use It on Patients?
TechnologyMed-PaLM 2: 86.5% on MedQA — Why Doctors Won't Use It (2026)
ResearchDr. Elena Rostova, MD, PhD
Dr. Rostova is a clinical informatics specialist with 14 years of research in machine-learning systems for diagnostic decision support at Stanford Medical Center.
Expert Takeaway
In Singapore, the tool is only part of the decision. The deployer must be able to explain the intended use, the data flow, the human oversight, and the escalation path. A product that cannot answer those four questions is not ready for clinical use.
Browse by Topic
QFrequently Asked Questions
Q1What is the best medical AI in Singapore in 2026?
It depends on the user. Premedice is strongest for cited lab explanations, Ada and Ubie are strong structured symptom tools, DrKhan is the simplest anonymous option, and HealthHub is the local health-system front door. Clinicians should use an institution-approved tool or a product with a clear AIHGle and PDPA assessment.
Q2What is AIHGle 2.0?
AIHGle 2.0 is the refreshed AI in Healthcare Guidelines issued by Singapore's Ministry of Health and Health Sciences Authority in March 2026. It sets responsibilities for developers, healthcare organisations, and clinicians, and emphasises human oversight, transparency, and risk mitigation.
Q3Does HSA regulate medical AI?
HSA regulates AI as a medical device by intended use. Software that diagnoses, monitors, treats, or manages a medical condition can be a medical device. Software that only displays information or follows established guidelines may fall outside device regulation.
Q4Can patient data be processed outside Singapore?
Yes, under the PDPA's transfer requirements. The recipient must be bound by legally enforceable obligations or hold a specified certification, and the transfer must provide a comparable standard of protection. A HIPAA BAA alone is not a PDPA solution.
Q5Is ChatGPT available in Singapore for health questions?
Yes, but a consumer ChatGPT account is not a healthcare service and should not receive identifiable patient information. Use de-identified information, and use a governed clinical tool for anything that affects care.
Q6Do I need consent for an AI scribe in Singapore?
Plan on yes. The SMC's revised Ethical Code requires consent for audio or visual recordings unless the recording is integral to assessment or treatment. Read every note before you sign it; records made on your behalf are still your responsibility.
Q7What is the Health Information Act?
The Health Information Act, passed in January 2026, requires licensed providers to contribute key health information to the National Electronic Health Record and to implement cybersecurity and data-security measures on a phased timeline from 2027.
Q8Which Singapore hospitals use AI?
Singapore General Hospital, Changi General Hospital, and the National University Hospital have been recognised for healthcare AI innovation. SingHealth uses Note Buddy for clinical documentation, and Synapxe provides shared AI infrastructure for the public healthcare system.
Verified References & Literature
Updated MOH Artificial Intelligence in Healthcare Guidelines (AIHGle 2.0)
Health Care Services Agency, Singapore, 2026
View SourceArtificial Intelligence in Healthcare Guidelines (AIHGle 2.0)
Ministry of Health and Health Sciences Authority, Singapore, 2026
View SourceGet a structured second read in seconds
Upload lab results, describe symptoms, or ask about a diagnosis — Premedice gives you medically-grounded answers backed by 30+ clinical databases.





